Peter Alter

Peter Alter (born 22 July 1940 in Parchim) is emeritus professor of modern and contemporary history at the University of Duisburg-Essen, Germany, and a specialist in nationalism and the twentieth century history of the United Kingdom. He is a former research fellow and deputy director of the German Historical Institute London. Provided by Wikipedia
Showing 1 - 20 results of 21 for search 'Peter Alter', query time: 0.08s Refine Results
  1. 1
    Feasibility and safety of whole-body vibration therapy in intensive care patients

    Feasibility and safety of whole-body vibration therapy in intensive care patients by Peter Alter, Tobias Boeselt, Christoph Nell, Marc Spielmanns, Klaus Kenn, A. Rembert Koczulla

    Published 2017-04-01
    Get full text
    Article
  2. 2
    High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients – a retrospective analysis

    High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients – a retrospective analysis by Timm Greulich, Julia Tüffers, Sina Mager, Anna Eder, Michael Maxheim, Peter Alter, Bernd Schmeck, Claus F. Vogelmeier

    Published 2020-05-01
    Get full text
    Article
  3. 3
    Randomized clinical trial shows no substantial modulation of empathy-related neural activation by intranasal oxytocin in autism

    Randomized clinical trial shows no substantial modulation of empathy-related neural activation by intranasal oxytocin in autism by Annalina V. Mayer, Anne-Kathrin Wermter, Sanna Stroth, Peter Alter, Michael Haberhausen, Thomas Stehr, Frieder M. Paulus, Sören Krach, Inge Kamp-Becker

    Published 2021-07-01
    Get full text
    Article
  4. 4
    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach by Kathrin Kahnert, Peter Alter, Tobias Welte, Rudolf M. Huber, Jürgen Behr, Frank Biertz, Henrik Watz, Robert Bals, Claus F. Vogelmeier, Rudolf A. Jörres

    Published 2018-06-01
    Get full text
    Article
  5. 5
    Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD

    Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD by Peter Alter, Henrik Watz, Kathrin Kahnert, Klaus F. Rabe, Frank Biertz, Ronald Fischer, Philip Jung, Jana Graf, Robert Bals, Claus F. Vogelmeier, Rudolf A. Jörres

    Published 2019-03-01
    Get full text
    Article
  6. 6
    Validity and Usability of Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease (COPD).

    Validity and Usability of Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease (COPD). by Tobias Boeselt, Marc Spielmanns, Christoph Nell, Jan Hendrik Storre, Wolfram Windisch, Lena Magerhans, Bjoern Beutel, Klaus Kenn, Timm Greulich, Peter Alter, Claus Vogelmeier, Andreas Rembert Koczulla

    Published 2016-01-01
    Get full text
    Article
  7. 7
    Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion

    Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion by Khodr Tello, Andreas Hoffmann, Björn Beutel, Timm Greulich, Claus Franz Vogelmeier, Manuel Jonas Richter, Stefan Kuhnert, Tobias Böselt, Peter Alter, Angelique Holland, Marco Idzko, Roland Buhl, Andreas Rembert Koczulla

    Published 2019-01-01
    Get full text
    Article
  8. 8
    Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort

    Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort by Peter Alter, Kathrin Kahnert, Franziska C. Trudzinski, Robert Bals, Henrik Watz, Tim Speicher, Sandra Söhler, Tobias Welte, Klaus F. Rabe, Emiel F. M. Wouters, Claus F. Vogelmeier, Rudolf A. Jörres

    Published 2023-11-01
    Get full text
    Article
  9. 9
    Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET

    Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET by Kathrin Kahnert, Johanna I. Lutter, Tobias Welte, Peter Alter, Jürgen Behr, Felix Herth, Hans-Ulrich Kauczor, Sandra Söhler, Michael Pfeifer, Henrik Watz, Claus F. Vogelmeier, Robert Bals, Rudolf A. Jörres, Franziska C. Trudzinski

    Published 2021-08-01
    Get full text
    Article
  10. 10
    Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study

    Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study by Sarah Marietta von Siemens, Rudolf A. Jörres, Jürgen Behr, Peter Alter, Johanna Lutter, Tanja Lucke, Sandra Söhler, Tobias Welte, Henrik Watz, Claus F. Vogelmeier, Franziska Trudzinski, Winfried Rief, Britta Herbig, Kathrin Kahnert, for the COSYCONET study group

    Published 2019-02-01
    Get full text
    Article
  11. 11
    Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study)

    Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study) by Klaus Kenn, Paul W Jones, Carmen Schade-Brittinger, Rainer Gloeckl, Daniela Leitl, Tessa Schneeberger, Inga Jarosch, Wolfgang Hitzl, Peter Alter, Bernd Sczepanski, Sandra Winterkamp, Martina Boensch, Chrysanthi Skevaki, Olaf Holz, Claus F Vogelmeier, Andreas R Koczulla

    Published 2021-02-01
    Get full text
    Article
  12. 12
    Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

    Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET by Jennifer A. Zader, Rudolf A. Jörres, Imke Mayer, Peter Alter, Robert Bals, Henrik Watz, Pontus Mertsch, Klaus F. Rabe, Felix Herth, Franziska C. Trudzinski, Tobias Welte, Hans-Ulrich Kauczor, Jürgen Behr, Julia Walter, Claus F. Vogelmeier, Kathrin Kahnert

    Published 2024-03-01
    Get full text
    Article
  13. 13
    Cardiovascular predictors of mortality and exacerbations in patients with COPD

    Cardiovascular predictors of mortality and exacerbations in patients with COPD by Peter Alter, Tanja Lucke, Henrik Watz, Stefan Andreas, Kathrin Kahnert, Franziska C. Trudzinski, Tim Speicher, Sandra Söhler, Robert Bals, Benjamin Waschki, Tobias Welte, Klaus F. Rabe, Jørgen Vestbo, Emiel F. M. Wouters, Claus F. Vogelmeier, Rudolf A. Jörres

    Published 2022-12-01
    Get full text
    Article
  14. 14
    Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment

    Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment by Kathrin Kahnert, Stefan Andreas, Christina Kellerer, Johanna I. Lutter, Tanja Lucke, Önder Yildirim, Mareike Lehmann, Jochen Seissler, Jürgen Behr, Marion Frankenberger, Robert Bals, Henrik Watz, Tobias Welte, Franziska C. Trudzinski, Claus F. Vogelmeier, Peter Alter, Rudolf A. Jörres, COSYCONET Study Group

    Published 2022-01-01
    Get full text
    Article
  15. 15
    Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET

    Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET by Franziska C. Trudzinski, Rudolf A. Jörres, Peter Alter, Julia Walter, Henrik Watz, Andrea Koch, Matthias John, Marek Lommatzsch, Claus F. Vogelmeier, Hans-Ulrich Kauczor, Tobias Welte, Jürgen Behr, Amanda Tufman, Robert Bals, Felix J. F. Herth, Kathrin Kahnert, The COSYCONET Study Group

    Published 2022-05-01
    Get full text
    Article
  16. 16
    Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET

    Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET by Christina Kellerer, Rudolf A. Jörres, Antonius Schneider, Peter Alter, Hans-Ulrich Kauczor, Bertram Jobst, Jürgen Biederer, Robert Bals, Henrik Watz, Jürgen Behr, Diego Kauffmann-Guerrero, Johanna Lutter, Alexander Hapfelmeier, Helgo Magnussen, Franziska C. Trudzinski, Tobias Welte, Claus F. Vogelmeier, Kathrin Kahnert

    Published 2021-09-01
    Get full text
    Article
  17. 17
    The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort

    The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort by Sarah Marietta von Siemens, Robert Perneczky, Claus F. Vogelmeier, Jürgen Behr, Diego Kauffmann-Guerrero, Peter Alter, Franziska C. Trudzinski, Robert Bals, Christian Grohé, Sandra Söhler, Benjamin Waschki, Johanna I. Lutter, Tobias Welte, Rudolf A. Jörres, Kathrin Kahnert, the COSYCONET study group

    Published 2019-11-01
    Get full text
    Article
  18. 18
    Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality

    Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality by Kathrin Kahnert, Rudolf A. Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C. Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus F. Rabe, Tobias Welte, Claus F. Vogelmeier, Jürgen Biederer

    Published 2023-01-01
    Get full text
    Article
  19. 19
    Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration

    Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration by Judith M Vonk, Torben Sigsgaard, Kian Fan Chung, Lies Lahousse, Maarten van den Berge, Jadwiga A Wedzicha, Judith Garcia-Aymerich, Anne Lindberg, Claus Vogelmeier, Helena Backman, Eva Rönmark, Ian M Adcock, Peter Alter, Alvar Agustí, Gavin C Donaldson, Guy G Brusselle, Rosa Faner, Howraman Meteran, Ahmed Edris, Nazanin Zounemat Kermani, Xander Bertels, Nuria Olvera

    Published 2023-07-01
    Get full text
    Article
  20. 20
    Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)

    Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD) by Franziska C. Trudzinski, Rudolf A. Jörres, Peter Alter, Henrik Watz, Claus F. Vogelmeier, Hans-Ulrich Kauczor, Subasini Thangamani, Manuel Debic, Tobias Welte, Jürgen Behr, Kathrin Kahnert, Robert Bals, Christian Herr, Claus Peter Heußel, Jürgen Biederer, Oyunbileg von Stackelberg, Sebastian Fähndrich, Emiel F. M. Wouters, Benjamin Waschki, Klaus F. Rabe, Felix J. F. Herth, Viktoria Palm, COSYCONET study group

    Published 2024-07-01
    Get full text
    Article

Search Tools: